Komori
M&A and Subsidiary Changes7707Precision System Science Co.,Ltd.Electrical equipment and precision instruments

Notice Regarding the Completion of the Transfer of Shares in a Consolidated Subsidiary (Progress of Disclosed Matter)

The company transferred all shares of its consolidated subsidiary Universal Bio Research Co., Ltd. (UBR) to Tajima Shuji (田島秀二) and completed the transfer effective 1 January 2025. As a result, UBR will be excluded from the scope of consolidation.

Worth reading
27Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

This transaction

This share transfer
Counterparty田島 秀二 氏
Disclosing companyPrecision System Science Co.,Ltd.
ユニバーサル・バイオ・リサーチ株式会社Subject of this transactionNumber of shares acquired 全株式(株数はNot disclosed)
Execution Date / Effective Date2025年1月1日付(完了)
Impact on Business Performance

2024年8月14日公表の「2024年6月決算短信〔日本基準〕(連結)」を参照

Procedures and assumptions
Management structure after acquisitionUBRは当社の連結対象から外れる
This transaction
ItemDetails
Transaction nameThis share transfer
Counterparty name田島 秀二 氏
Name of the Subject Companyユニバーサル・バイオ・リサーチ株式会社
Number of shares acquired全株式(株数はNot disclosed)
Impact on Business Performance2024年8月14日公表の「2024年6月決算短信〔日本基準〕(連結)」を参照
Execution Date / Effective Date2025年1月1日付(完了)
Management structure after acquisitionUBRは当社の連結対象から外れる
Items this document does not state (25)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

本書類では、株式譲渡の理由は説明されていません。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Completion of the Transfer of Shares in a Consolidated Subsidiary (Progress of Disclosed Matter) | Precision System Science Co.,Ltd. (7707) timely disclosure | Komori